Replimune Group Inc (NASDAQ: REPL) established initial surge of 8.97% at $4.74, as the Stock market unbolted on Wednesday, before settling in for the price of $4.35 at the close. Taking a more long-term approach, REPL posted a 52-week range of $2.68-$17.00.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -14.85%. Meanwhile, its Annual Earning per share during the time was -14.85%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 5.68%. This publicly-traded company’s shares outstanding now amounts to $77.81 million, simultaneously with a float of $66.34 million. The organization now has a market capitalization sitting at $369.98 million.
Replimune Group Inc (REPL) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Replimune Group Inc industry. Replimune Group Inc’s current insider ownership accounts for 15.01%, in contrast to 96.85% institutional ownership. According to the most recent insider trade that took place on Aug 15 ’25, this organization’s Chief Financial Officer sold 9,154 shares at the rate of 5.37, making the entire transaction reach 49,157 in total value, affecting insider ownership by 134,368. Preceding that transaction, on May 20 ’25, Company’s Director sold 32,279 for 8.06, making the whole transaction’s value amount to 260,169. This particular insider is now the holder of 1,405,071 in total.
Replimune Group Inc (REPL) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.78 per share during the current fiscal year.
Replimune Group Inc’s EPS increase for this current 12-month fiscal period is 5.68% and is forecasted to reach -1.75 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 22.85% through the next 5 years, which can be compared against the -14.85% growth it accomplished over the previous five years trading on the market.
Replimune Group Inc (NASDAQ: REPL) Trading Performance Indicators
Let’s observe the current performance indicators for Replimune Group Inc (REPL). It’s Quick Ratio in the last reported quarter now stands at 6.94.
In the same vein, REPL’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.38, a figure that is expected to reach -0.75 in the next quarter, and analysts are predicting that it will be -1.75 at the market close of one year from today.
